What Is Xylazine and Why Is It in Philly's Drug Supply?
Xylazine is a veterinary sedative — it is not approved for human use. Drug traffickers began mixing it with fentanyl because it extends the duration of the drug's effects, helps suppress withdrawal, and increases the weight and profitability of the product. Philadelphia has been one of the cities hit hardest: xylazine was still detected in 34% of the city's overdose deaths in 2024, and 99% of those deaths also involved fentanyl (PDPH 2024 report). Xylazine is not an opioid — naloxone does not reverse a xylazine overdose. In a combined fentanyl-xylazine overdose, naloxone may reverse the fentanyl component, but the person may remain sedated due to xylazine.
What Are Xylazine Wounds?
One of the most distinctive harms from xylazine is the severe, slow-healing skin ulcerations it causes — often called 'tranq wounds.' These wounds can appear anywhere on the body (not just injection sites) and can progress rapidly if untreated, in some cases requiring amputation. Many people entering Philadelphia inpatient treatment programs have active xylazine wounds that require coordinated wound care alongside addiction treatment. Choosing a program with experience managing tranq wounds is important for Philadelphia patients.
What Is Medetomidine — And Has It Replaced Xylazine?
Largely, yes. In the last four months of 2024, medetomidine was detected in 72% of illegal opioid samples tested in Philadelphia while xylazine fell from 98% to 31% (CDC MMWR). Like xylazine, it is an alpha-2 adrenergic agonist. The CDC describes medetomidine withdrawal as profound autonomic dysfunction, such as severe hypertension and tachycardia, with agitation, tremor and vomiting also reported, and notes it resisted escalating doses of opioids and sedatives. This is why attempting home detox from Philadelphia street drugs is so dangerous — the withdrawal from adulterants alone can be medically serious.
What Does Xylazine / Medetomidine Detox Involve?
Because xylazine and medetomidine are not opioids, opioid withdrawal protocols alone are insufficient. Clinical teams managing these patients use protocols aimed at the specific withdrawal syndrome alongside opioid withdrawal management for the fentanyl component. Wound care is integrated into the treatment plan for patients with xylazine injuries. This specialized protocol requires clinical experience — it's one reason Philadelphia-specific placement expertise matters.
Ready to Talk? Call (215) 792-4574 — Available 24/7.
Free insurance verification in minutes. We tell you what your plan covers in one call. Confidential, no obligation.